Other
Casa Espirita Terra de Ismael
Total Trials
6
Recruiting
0
Active
0
Completed
4
Success Rate
66.7%-20% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
Failure Rate
33.3%
2 terminated/withdrawn out of 6 trials
Success Rate
66.7%
-19.8% vs industry average
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 2
2(33.3%)
Phase 4
2(33.3%)
Phase 3
1(16.7%)
Phase 1
1(16.7%)
6Total
Phase 2(2)
Phase 4(2)
Phase 3(1)
Phase 1(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT04035317Phase 2Withdrawn
Aesculus Hippocastanum L. on Fontan Circulation
Role: lead
NCT02519556Phase 4Completed
Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children
Role: lead
NCT03388866Phase 4Completed
Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis
Role: lead
NCT01408849Phase 2Terminated
Use of Maytenus Ilicifolia in the Treatment of Dyspepsia
Role: lead
NCT01315041Phase 1Completed
"Pi" and Hot Flushes
Role: lead
NCT01414374Phase 3Completed
Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency
Role: lead
All 6 trials loaded